Skip to main content
OpenTrials

Clinical trial condition

Endocrine Gland Neoplasms

Explore clinical trials studying Endocrine Gland Neoplasms. Study availability and eligibility vary by location and protocol.

6,077 public trials 1,365 recruiting studies
Refine in advanced search Browse all conditions

Endocrine Gland Neoplasms trial results

Completed

Study of OSI-211 vs. Topotecan in Patients With Relapsed Epithelial Ovarian Cancer

NCT00046800

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +12 more
Locations
  • NYU- Kaplan Comprehensive Cancer Center New York, United States
  • The Sarah Cannon Cancer Center, Centennial Medical Center Nashville, Tennessee, United States
  • St Chad's Unit Birmingham, United Kingdom
  • Beatson Oncology Centre Glasgow, United Kingdom
View Trial Details
Completed

Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer

NCT01016639

Conditions
Bile Ductus Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +23 more
Locations
  • Centralsjukhuset, Dept of Oncology Karlstad, Sweden
  • University Hospital Lund Lund, Sweden
  • University Hospital Malmö, Dept of Oncology Malmö, Sweden
  • Karolinska University Hospital Stockholm, Sweden
View Trial Details
Completed

Study of XL281 in Adults With Solid Tumors

NCT00451880

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Bronchial Neoplasms, +40 more
Locations
  • Premiere Oncology of Arizona Scottsdale, Arizona, United States
  • H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Completed

Phase 1 Study of OSI-930 in Cancer Patients

NCT00513851

Conditions
Adnexal Diseases, Advanced Solid Tumors, Bronchial Neoplasms, +49 more
Locations
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Cancer Research UK Professor of Medical Oncology Sutton, Surrey, United Kingdom
View Trial Details

Related conditions